Project objectivesEvaluation of the safety and performance of the left atrial occlusion device (Omega) in patients with non-valvular atrial fibrillation and high risk of hemorrhage |
Start and end date |
| May 2022 - ongoing Approximate end December 2023 |
Project Manager |
| Prof. Gian Paolo Ussia |
Coordinating institution of the project |
| Eclipse Medical Ltd. |